Valvular & structural heart diseaseCohort study
Advancing Quality in the Evaluation, Surveillance, and Management of Aortic Stenosis: A Report From the AHA Target: Aortic Stenosis (AS) Registry
- Registry-based quality-of-care study
- national registry
- 58 sites
- randomly selected patients
Authors' conclusion
The national American Heart Association Target: AS registry demonstrates opportunities for improvement in timely diagnosis, surveillance, and treatment for patients with AS at participating centers.
Study context
- Population
- Patients with moderate or severe AS, AHA Target: AS registry, 2023 and 2024
- Participants
- 8,097 patients · 58 sites
- Exposure
- 2023 vs 2024
- Outcome
- Timely diagnosis (all assessments to clarify AS severity and symptoms within 30 days of an echocardiogram consistent with possible severe AS) and timely treatment (Class I indication for AVR treated within 90 days)
Main finding
As reported in the abstract
Timely diagnosis
P = 0.027
Timely treatment
P = NS
Observational data: associations, not effects.
Further findings
Gaps in timely diagnosis
Lack of timely symptom assessment
Lack of stroke volume index
Lack of timely multimodality testing
Multidisciplinary heart valve team evaluation
P = 0.008
Key findings documented in echocardiography report
P = NS
Clinical recommendation in echocardiography report
- Clinical recommendation included
- <10%
Timely surveillance echocardiograms (moderate AS 2 years; severe AS 1 year)
- Not performed
- ~40%
Original publication
Summarised from the published abstract; every number is checked against it